Patents by Inventor Chi GAN

Chi GAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • T CELL RECEPTOR TARGETING KRAS G12V MUTANT POLYPEPTIDE, AND USE THEREOF
    Publication number: 20260174849
    Abstract: A T cell receptor targeting a KRAS G12V mutant polypeptide and a use thereof, wherein the T cell receptor molecule specifically targets a KRAS G12V mutation; a CDR3 sequence of an ? chain variable domain thereof contains CAVRDIEGAGNNRKLIW (SEQ ID NO: 1) or a mutant of SEQ ID NO: 1, and/or a CDR3 sequence of a ? chain variable domain contains CASSEGQYSYEQYF (SEQ ID NO: 2) or a mutant of SEQ ID NO: 2. Furthermore, a nucleic acid molecule encodes the T cell receptor molecule, a dual-targeting protein molecule and a multivalent complex includes the T cell receptor molecule, a nucleic acid construct, a cell expressing the T cell receptor molecule, etc.
    Type: Application
    Filed: June 12, 2023
    Publication date: June 25, 2026
    Applicant: IMMUXELL BIOTECH LTD.
    Inventors: Xuemei ZOU, Xiaohui ZHANG, Chi GAN, Maorong WEN, Guangjie YU